chr19:10982299-11033853 |
chr19:10987013 |
rs1541596 |
CARM1 |
Rheumatoid arthritis |
intron |
9.43e-05 |
GWASdb |
| chr19:10982299-11033853 |
chr19:10987013 |
rs1541596 |
CARM1 |
LDL lipoproteins |
intron |
8.97e-05 |
GWASdb |
| chr19:10982299-11033853 |
chr19:11002862 |
rs1549926 |
CARM1 |
Eosinophil counts |
intron |
7.05e-05 |
GWASdb |
| chr19:10982299-11033853 |
chr19:11023434 |
rs1529711 |
CARM1 |
Familial hypercholesterolemia (LDL receptor mutation present) |
intron |
1.52e-13 |
GWASdb |
| chr19:10982299-11033853 |
chr19:11023434 |
rs1529711 |
CARM1 |
Familial hypercholesterolemia |
intron |
8.58e-12 |
GWASdb |
| chr19:10982449-11034101 |
chr19:10987013 |
rs1541596 |
CARM1 |
Rheumatoid arthritis |
intron |
9.43e-05 |
GWASdb |
| chr19:10982449-11034101 |
chr19:10987013 |
rs1541596 |
CARM1 |
LDL lipoproteins |
intron |
8.97e-05 |
GWASdb |
| chr19:10982449-11034101 |
chr19:11002862 |
rs1549926 |
CARM1 |
Eosinophil counts |
intron |
7.05e-05 |
GWASdb |
| chr19:10982449-11034101 |
chr19:11023434 |
rs1529711 |
CARM1 |
Familial hypercholesterolemia (LDL receptor mutation present) |
intron |
1.52e-13 |
GWASdb |
| chr19:10982449-11034101 |
chr19:11023434 |
rs1529711 |
CARM1 |
Familial hypercholesterolemia |
intron |
8.58e-12 |
GWASdb |
| chr19:10974836-11037034 |
chr19:10987013 |
rs1541596 |
CARM1 |
Rheumatoid arthritis |
intron |
9.43e-05 |
GWASdb |
| chr19:10974836-11037034 |
chr19:10987013 |
rs1541596 |
CARM1 |
LDL lipoproteins |
intron |
8.97e-05 |
GWASdb |
| chr19:10974836-11037034 |
chr19:11002862 |
rs1549926 |
CARM1 |
Eosinophil counts |
intron |
7.05e-05 |
GWASdb |
| chr19:10974836-11037034 |
chr19:11023434 |
rs1529711 |
CARM1 |
Familial hypercholesterolemia (LDL receptor mutation present) |
intron |
1.52e-13 |
GWASdb |
| chr19:10974836-11037034 |
chr19:11023434 |
rs1529711 |
CARM1 |
Familial hypercholesterolemia |
intron |
8.58e-12 |
GWASdb |
| chr19:10974836-11037034 |
chr19:10981463 |
rs11669133 |
SMARCA4 |
LDL cholesterol |
intron_variant |
1e-08 |
GWAS_Catalog |
| chr19:11123214-11136337 |
chr19:11136315 |
rs2075022 |
SMARCA4 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
1.38e-06 |
GWASdb |
| chr19:11123214-11136337 |
chr19:11127797 |
rs2738459 |
LDLR |
LDL cholesterol |
intron_variant |
7e-06 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11065409 |
rs11085752 |
NA |
Lipoprotein-associated phospholipase A2 activity and mass |
NA |
3e-05 |
GWASdb |
| chr19:11049687-11091797 |
chr19:11072610 |
rs11879293 |
SMARCA4 |
Myocardial Infarction |
intron |
0.000354 |
GWASdb |
| chr19:11049687-11091797 |
chr19:11072610 |
rs11879293 |
SMARCA4 |
LDL lipoproteins |
intron |
7.54e-05 |
GWASdb |
| chr19:11049687-11091797 |
chr19:11084994 |
rs12610607 |
SMARCA4 |
Eosinophil counts |
intron |
5e-05 |
GWASdb |
| chr19:11049687-11091797 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
4e-26 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11084354 |
rs11668477 |
SMARCA4 - LDLR |
LDL cholesterol |
intergenic_variant |
2e-07 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
2e-26 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11052925 |
rs1122608 |
SMARCA4 |
Myocardial infarction (early onset) |
intron_variant |
2e-09 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11091630 |
rs6511720 |
LDLR |
Carotid intima media thickness |
intron_variant |
1e-07 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11091630 |
rs6511720 |
LDLR |
Cardiovascular disease risk factors |
intron_variant |
5e-11 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipoprotein-associated phospholipase A2 activity and mass |
intron_variant |
3e-11 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
4e-117 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11091630 |
rs6511720 |
LDLR |
Cholesterol, total |
intron_variant |
7e-97 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11052925 |
rs1122608 |
SMARCA4 |
Coronary heart disease |
intron_variant |
1e-09 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11077477 |
rs55791371 |
SMARCA4 - LDLR |
Lipid metabolism phenotypes |
intergenic_variant |
8e-17 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11091630 |
rs6511720 |
LDLR |
Metabolite levels |
intron_variant |
4e-09 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipid metabolism phenotypes |
intron_variant |
5e-25 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipid metabolism phenotypes |
intron_variant |
3e-18 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipid metabolism phenotypes |
intron_variant |
1e-25 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipid metabolism phenotypes |
intron_variant |
2e-31 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11091630 |
rs6511720 |
LDLR |
Abdominal aortic aneurysm |
intron_variant |
2e-10 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11052925 |
rs1122608 |
SMARCA4 |
Coronary artery disease or ischemic stroke |
intron_variant |
3e-12 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11052925 |
rs1122608 |
SMARCA4 |
Coronary artery disease or large artery stroke |
intron_variant |
2e-11 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
3e-115 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11089332 |
rs17249141 |
SMARCA4 - LDLR |
LDL cholesterol |
upstream_gene_variant |
2e-17 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
4e-262 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11091630 |
rs6511720 |
LDLR |
Cholesterol, total |
intron_variant |
5e-202 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
2e-51 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
7e-08 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11077571 |
rs56289821 |
SMARCA4 - LDLR |
Coronary artery disease |
intergenic_variant |
4e-15 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11063949 |
rs8099996 |
SMARCA4 - LDLR |
Inflammatory skin disease |
intron_variant |
3e-06 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11078223 |
rs112374545 |
SMARCA4 - LDLR |
Cholesterol, total |
intergenic_variant |
2e-113 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11078223 |
rs112374545 |
SMARCA4 - LDLR |
LDL cholesterol |
intergenic_variant |
7e-142 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11077477 |
rs55791371 |
SMARCA4 - LDLR |
Myocardial infarction |
intergenic_variant |
3e-08 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11091630 |
rs6511720 |
LDLR |
Abdominal aortic aneurysm |
intron_variant |
8e-14 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11052925 |
rs1122608 |
SMARCA4 |
Coronary artery disease |
intron_variant |
3e-11 |
GWAS_Catalog |
| chr19:11049687-11091797 |
chr19:11079976 |
rs142130958 |
SMARCA4 - LDLR |
Metabolite levels (lipoprotein measures) |
intergenic_variant |
7e-47 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11065409 |
rs11085752 |
NA |
Lipoprotein-associated phospholipase A2 activity and mass |
NA |
3e-05 |
GWASdb |
| chr19:11049603-11092720 |
chr19:11072610 |
rs11879293 |
SMARCA4 |
Myocardial Infarction |
intron |
0.000354 |
GWASdb |
| chr19:11049603-11092720 |
chr19:11072610 |
rs11879293 |
SMARCA4 |
LDL lipoproteins |
intron |
7.54e-05 |
GWASdb |
| chr19:11049603-11092720 |
chr19:11084994 |
rs12610607 |
SMARCA4 |
Eosinophil counts |
intron |
5e-05 |
GWASdb |
| chr19:11049603-11092720 |
chr19:11092139 |
rs11669133 |
SMARCA4 |
Coronary heart disease |
intron |
1e-08 |
GWASdb |
| chr19:11049603-11092720 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
4e-26 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11084354 |
rs11668477 |
SMARCA4 - LDLR |
LDL cholesterol |
intergenic_variant |
2e-07 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
2e-26 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11052925 |
rs1122608 |
SMARCA4 |
Myocardial infarction (early onset) |
intron_variant |
2e-09 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11091630 |
rs6511720 |
LDLR |
Carotid intima media thickness |
intron_variant |
1e-07 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11091630 |
rs6511720 |
LDLR |
Cardiovascular disease risk factors |
intron_variant |
5e-11 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipoprotein-associated phospholipase A2 activity and mass |
intron_variant |
3e-11 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
4e-117 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11091630 |
rs6511720 |
LDLR |
Cholesterol, total |
intron_variant |
7e-97 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11052925 |
rs1122608 |
SMARCA4 |
Coronary heart disease |
intron_variant |
1e-09 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11077477 |
rs55791371 |
SMARCA4 - LDLR |
Lipid metabolism phenotypes |
intergenic_variant |
8e-17 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11091630 |
rs6511720 |
LDLR |
Metabolite levels |
intron_variant |
4e-09 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipid metabolism phenotypes |
intron_variant |
5e-25 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipid metabolism phenotypes |
intron_variant |
3e-18 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipid metabolism phenotypes |
intron_variant |
1e-25 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipid metabolism phenotypes |
intron_variant |
2e-31 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11091630 |
rs6511720 |
LDLR |
Abdominal aortic aneurysm |
intron_variant |
2e-10 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11052925 |
rs1122608 |
SMARCA4 |
Coronary artery disease or ischemic stroke |
intron_variant |
3e-12 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11052925 |
rs1122608 |
SMARCA4 |
Coronary artery disease or large artery stroke |
intron_variant |
2e-11 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
3e-115 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11089332 |
rs17249141 |
SMARCA4 - LDLR |
LDL cholesterol |
upstream_gene_variant |
2e-17 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
4e-262 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11091630 |
rs6511720 |
LDLR |
Cholesterol, total |
intron_variant |
5e-202 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
2e-51 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
7e-08 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11077571 |
rs56289821 |
SMARCA4 - LDLR |
Coronary artery disease |
intergenic_variant |
4e-15 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11063949 |
rs8099996 |
SMARCA4 - LDLR |
Inflammatory skin disease |
intron_variant |
3e-06 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11078223 |
rs112374545 |
SMARCA4 - LDLR |
Cholesterol, total |
intergenic_variant |
2e-113 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11078223 |
rs112374545 |
SMARCA4 - LDLR |
LDL cholesterol |
intergenic_variant |
7e-142 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11077477 |
rs55791371 |
SMARCA4 - LDLR |
Myocardial infarction |
intergenic_variant |
3e-08 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11091630 |
rs6511720 |
LDLR |
Abdominal aortic aneurysm |
intron_variant |
8e-14 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11052925 |
rs1122608 |
SMARCA4 |
Coronary artery disease |
intron_variant |
3e-11 |
GWAS_Catalog |
| chr19:11049603-11092720 |
chr19:11079976 |
rs142130958 |
SMARCA4 - LDLR |
Metabolite levels (lipoprotein measures) |
intergenic_variant |
7e-47 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11065409 |
rs11085752 |
NA |
Lipoprotein-associated phospholipase A2 activity and mass |
NA |
3e-05 |
GWASdb |
| chr19:11064423-11092418 |
chr19:11072610 |
rs11879293 |
SMARCA4 |
Myocardial Infarction |
intron |
0.000354 |
GWASdb |
| chr19:11064423-11092418 |
chr19:11072610 |
rs11879293 |
SMARCA4 |
LDL lipoproteins |
intron |
7.54e-05 |
GWASdb |
| chr19:11064423-11092418 |
chr19:11084994 |
rs12610607 |
SMARCA4 |
Eosinophil counts |
intron |
5e-05 |
GWASdb |
| chr19:11064423-11092418 |
chr19:11092139 |
rs11669133 |
SMARCA4 |
Coronary heart disease |
intron |
1e-08 |
GWASdb |
| chr19:11064423-11092418 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
4e-26 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11084354 |
rs11668477 |
SMARCA4 - LDLR |
LDL cholesterol |
intergenic_variant |
2e-07 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
2e-26 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11091630 |
rs6511720 |
LDLR |
Carotid intima media thickness |
intron_variant |
1e-07 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11091630 |
rs6511720 |
LDLR |
Cardiovascular disease risk factors |
intron_variant |
5e-11 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipoprotein-associated phospholipase A2 activity and mass |
intron_variant |
3e-11 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
4e-117 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11091630 |
rs6511720 |
LDLR |
Cholesterol, total |
intron_variant |
7e-97 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11077477 |
rs55791371 |
SMARCA4 - LDLR |
Lipid metabolism phenotypes |
intergenic_variant |
8e-17 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11091630 |
rs6511720 |
LDLR |
Metabolite levels |
intron_variant |
4e-09 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipid metabolism phenotypes |
intron_variant |
5e-25 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipid metabolism phenotypes |
intron_variant |
3e-18 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipid metabolism phenotypes |
intron_variant |
1e-25 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipid metabolism phenotypes |
intron_variant |
2e-31 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11091630 |
rs6511720 |
LDLR |
Abdominal aortic aneurysm |
intron_variant |
2e-10 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
3e-115 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11089332 |
rs17249141 |
SMARCA4 - LDLR |
LDL cholesterol |
upstream_gene_variant |
2e-17 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
4e-262 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11091630 |
rs6511720 |
LDLR |
Cholesterol, total |
intron_variant |
5e-202 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
2e-51 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
7e-08 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11077571 |
rs56289821 |
SMARCA4 - LDLR |
Coronary artery disease |
intergenic_variant |
4e-15 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11078223 |
rs112374545 |
SMARCA4 - LDLR |
Cholesterol, total |
intergenic_variant |
2e-113 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11078223 |
rs112374545 |
SMARCA4 - LDLR |
LDL cholesterol |
intergenic_variant |
7e-142 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11077477 |
rs55791371 |
SMARCA4 - LDLR |
Myocardial infarction |
intergenic_variant |
3e-08 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11091630 |
rs6511720 |
LDLR |
Abdominal aortic aneurysm |
intron_variant |
8e-14 |
GWAS_Catalog |
| chr19:11064423-11092418 |
chr19:11079976 |
rs142130958 |
SMARCA4 - LDLR |
Metabolite levels (lipoprotein measures) |
intergenic_variant |
7e-47 |
GWAS_Catalog |
| chr19:11144971-11164826 |
chr19:11159096 |
rs12052201 |
SMARCA4 |
Multiple complex diseases |
intron |
0.000777 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11159525 |
rs12052058 |
SMARCA4 |
Multiple complex diseases |
intron |
0.000762 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Coronary Artery Disease |
intron |
0.000614 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Lipid levels |
intron |
4.52e-08 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
6.74e-05 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Cardiovascular disease risk factors |
intron |
3.06e-06 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Soluble ICAM-1 |
intron |
1.1e-10 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Cholesterol, total |
intron |
3.39e-11 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
LDL cholesterol |
intron |
5.64e-11 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Type 2 diabetes |
intron |
0.000794 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Multiple complex diseases |
intron |
0.00044 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Myocardial infarction (early onset) |
intron |
2e-09 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Cardiovascular disease risk factors |
intron |
3.18e-05 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary heart disease |
intron |
2e-09 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary heart disease |
intron |
1e-09 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Pericardial fat |
intron |
9.73e-10 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease (CAD) age >50 |
intron |
7e-07 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
LDL cholesterol |
intron |
1.24e-33 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease (CAD) age <=50 |
intron |
2.7e-09 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease (CAD) (males) |
intron |
4.52e-10 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Cholesterol, total |
intron |
4.59e-26 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease with myocardial infarction |
intron |
5.39e-08 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease or large artery stroke |
intron |
2e-11 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease |
intron |
3e-11 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease or ischemic stroke |
intron |
3e-12 |
GWASdb |
| chr19:11144971-11164826 |
chr19:11145500 |
rs4804146 |
SPC24 |
Lipid traits |
3_prime_UTR_variant |
7e-06 |
GWAS_Catalog |
| chr19:11141974-11164978 |
chr19:11159096 |
rs12052201 |
SMARCA4 |
Multiple complex diseases |
intron |
0.000777 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11159525 |
rs12052058 |
SMARCA4 |
Multiple complex diseases |
intron |
0.000762 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Coronary Artery Disease |
intron |
0.000614 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Lipid levels |
intron |
4.52e-08 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
6.74e-05 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Cardiovascular disease risk factors |
intron |
3.06e-06 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Soluble ICAM-1 |
intron |
1.1e-10 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Cholesterol, total |
intron |
3.39e-11 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
LDL cholesterol |
intron |
5.64e-11 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Type 2 diabetes |
intron |
0.000794 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Multiple complex diseases |
intron |
0.00044 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Myocardial infarction (early onset) |
intron |
2e-09 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Cardiovascular disease risk factors |
intron |
3.18e-05 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary heart disease |
intron |
2e-09 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary heart disease |
intron |
1e-09 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Pericardial fat |
intron |
9.73e-10 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease (CAD) age >50 |
intron |
7e-07 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
LDL cholesterol |
intron |
1.24e-33 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease (CAD) age <=50 |
intron |
2.7e-09 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease (CAD) (males) |
intron |
4.52e-10 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Cholesterol, total |
intron |
4.59e-26 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease with myocardial infarction |
intron |
5.39e-08 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease or large artery stroke |
intron |
2e-11 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease |
intron |
3e-11 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease or ischemic stroke |
intron |
3e-12 |
GWASdb |
| chr19:11141974-11164978 |
chr19:11145500 |
rs4804146 |
SPC24 |
Lipid traits |
3_prime_UTR_variant |
7e-06 |
GWAS_Catalog |
| chr19:11144853-11165413 |
chr19:11159096 |
rs12052201 |
SMARCA4 |
Multiple complex diseases |
intron |
0.000777 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11159525 |
rs12052058 |
SMARCA4 |
Multiple complex diseases |
intron |
0.000762 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Coronary Artery Disease |
intron |
0.000614 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Lipid levels |
intron |
4.52e-08 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
6.74e-05 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Cardiovascular disease risk factors |
intron |
3.06e-06 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Soluble ICAM-1 |
intron |
1.1e-10 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Cholesterol, total |
intron |
3.39e-11 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
LDL cholesterol |
intron |
5.64e-11 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Type 2 diabetes |
intron |
0.000794 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Multiple complex diseases |
intron |
0.00044 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Myocardial infarction (early onset) |
intron |
2e-09 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Cardiovascular disease risk factors |
intron |
3.18e-05 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary heart disease |
intron |
2e-09 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary heart disease |
intron |
1e-09 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Pericardial fat |
intron |
9.73e-10 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease (CAD) age >50 |
intron |
7e-07 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
LDL cholesterol |
intron |
1.24e-33 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease (CAD) age <=50 |
intron |
2.7e-09 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease (CAD) (males) |
intron |
4.52e-10 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Cholesterol, total |
intron |
4.59e-26 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease with myocardial infarction |
intron |
5.39e-08 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease or large artery stroke |
intron |
2e-11 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease |
intron |
3e-11 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease or ischemic stroke |
intron |
3e-12 |
GWASdb |
| chr19:11144853-11165413 |
chr19:11145500 |
rs4804146 |
SPC24 |
Lipid traits |
3_prime_UTR_variant |
7e-06 |
GWAS_Catalog |
| chr19:11047216-11087582 |
chr19:11065409 |
rs11085752 |
NA |
Lipoprotein-associated phospholipase A2 activity and mass |
NA |
3e-05 |
GWASdb |
| chr19:11047216-11087582 |
chr19:11072610 |
rs11879293 |
SMARCA4 |
Myocardial Infarction |
intron |
0.000354 |
GWASdb |
| chr19:11047216-11087582 |
chr19:11072610 |
rs11879293 |
SMARCA4 |
LDL lipoproteins |
intron |
7.54e-05 |
GWASdb |
| chr19:11047216-11087582 |
chr19:11084994 |
rs12610607 |
SMARCA4 |
Eosinophil counts |
intron |
5e-05 |
GWASdb |
| chr19:11047216-11087582 |
chr19:11084354 |
rs11668477 |
SMARCA4 - LDLR |
LDL cholesterol |
intergenic_variant |
2e-07 |
GWAS_Catalog |
| chr19:11047216-11087582 |
chr19:11052925 |
rs1122608 |
SMARCA4 |
Myocardial infarction (early onset) |
intron_variant |
2e-09 |
GWAS_Catalog |
| chr19:11047216-11087582 |
chr19:11052925 |
rs1122608 |
SMARCA4 |
Coronary heart disease |
intron_variant |
1e-09 |
GWAS_Catalog |
| chr19:11047216-11087582 |
chr19:11077477 |
rs55791371 |
SMARCA4 - LDLR |
Lipid metabolism phenotypes |
intergenic_variant |
8e-17 |
GWAS_Catalog |
| chr19:11047216-11087582 |
chr19:11052925 |
rs1122608 |
SMARCA4 |
Coronary artery disease or ischemic stroke |
intron_variant |
3e-12 |
GWAS_Catalog |
| chr19:11047216-11087582 |
chr19:11052925 |
rs1122608 |
SMARCA4 |
Coronary artery disease or large artery stroke |
intron_variant |
2e-11 |
GWAS_Catalog |
| chr19:11047216-11087582 |
chr19:11077571 |
rs56289821 |
SMARCA4 - LDLR |
Coronary artery disease |
intergenic_variant |
4e-15 |
GWAS_Catalog |
| chr19:11047216-11087582 |
chr19:11063949 |
rs8099996 |
SMARCA4 - LDLR |
Inflammatory skin disease |
intron_variant |
3e-06 |
GWAS_Catalog |
| chr19:11047216-11087582 |
chr19:11078223 |
rs112374545 |
SMARCA4 - LDLR |
Cholesterol, total |
intergenic_variant |
2e-113 |
GWAS_Catalog |
| chr19:11047216-11087582 |
chr19:11078223 |
rs112374545 |
SMARCA4 - LDLR |
LDL cholesterol |
intergenic_variant |
7e-142 |
GWAS_Catalog |
| chr19:11047216-11087582 |
chr19:11077477 |
rs55791371 |
SMARCA4 - LDLR |
Myocardial infarction |
intergenic_variant |
3e-08 |
GWAS_Catalog |
| chr19:11047216-11087582 |
chr19:11052925 |
rs1122608 |
SMARCA4 |
Coronary artery disease |
intron_variant |
3e-11 |
GWAS_Catalog |
| chr19:11047216-11087582 |
chr19:11079976 |
rs142130958 |
SMARCA4 - LDLR |
Metabolite levels (lipoprotein measures) |
intergenic_variant |
7e-47 |
GWAS_Catalog |
| chr19:11047365-11088802 |
chr19:11065409 |
rs11085752 |
NA |
Lipoprotein-associated phospholipase A2 activity and mass |
NA |
3e-05 |
GWASdb |
| chr19:11047365-11088802 |
chr19:11072610 |
rs11879293 |
SMARCA4 |
Myocardial Infarction |
intron |
0.000354 |
GWASdb |
| chr19:11047365-11088802 |
chr19:11072610 |
rs11879293 |
SMARCA4 |
LDL lipoproteins |
intron |
7.54e-05 |
GWASdb |
| chr19:11047365-11088802 |
chr19:11084994 |
rs12610607 |
SMARCA4 |
Eosinophil counts |
intron |
5e-05 |
GWASdb |
| chr19:11047365-11088802 |
chr19:11084354 |
rs11668477 |
SMARCA4 - LDLR |
LDL cholesterol |
intergenic_variant |
2e-07 |
GWAS_Catalog |
| chr19:11047365-11088802 |
chr19:11052925 |
rs1122608 |
SMARCA4 |
Myocardial infarction (early onset) |
intron_variant |
2e-09 |
GWAS_Catalog |
| chr19:11047365-11088802 |
chr19:11052925 |
rs1122608 |
SMARCA4 |
Coronary heart disease |
intron_variant |
1e-09 |
GWAS_Catalog |
| chr19:11047365-11088802 |
chr19:11077477 |
rs55791371 |
SMARCA4 - LDLR |
Lipid metabolism phenotypes |
intergenic_variant |
8e-17 |
GWAS_Catalog |
| chr19:11047365-11088802 |
chr19:11052925 |
rs1122608 |
SMARCA4 |
Coronary artery disease or ischemic stroke |
intron_variant |
3e-12 |
GWAS_Catalog |
| chr19:11047365-11088802 |
chr19:11052925 |
rs1122608 |
SMARCA4 |
Coronary artery disease or large artery stroke |
intron_variant |
2e-11 |
GWAS_Catalog |
| chr19:11047365-11088802 |
chr19:11077571 |
rs56289821 |
SMARCA4 - LDLR |
Coronary artery disease |
intergenic_variant |
4e-15 |
GWAS_Catalog |
| chr19:11047365-11088802 |
chr19:11063949 |
rs8099996 |
SMARCA4 - LDLR |
Inflammatory skin disease |
intron_variant |
3e-06 |
GWAS_Catalog |
| chr19:11047365-11088802 |
chr19:11078223 |
rs112374545 |
SMARCA4 - LDLR |
Cholesterol, total |
intergenic_variant |
2e-113 |
GWAS_Catalog |
| chr19:11047365-11088802 |
chr19:11078223 |
rs112374545 |
SMARCA4 - LDLR |
LDL cholesterol |
intergenic_variant |
7e-142 |
GWAS_Catalog |
| chr19:11047365-11088802 |
chr19:11077477 |
rs55791371 |
SMARCA4 - LDLR |
Myocardial infarction |
intergenic_variant |
3e-08 |
GWAS_Catalog |
| chr19:11047365-11088802 |
chr19:11052925 |
rs1122608 |
SMARCA4 |
Coronary artery disease |
intron_variant |
3e-11 |
GWAS_Catalog |
| chr19:11047365-11088802 |
chr19:11079976 |
rs142130958 |
SMARCA4 - LDLR |
Metabolite levels (lipoprotein measures) |
intergenic_variant |
7e-47 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11072610 |
rs11879293 |
SMARCA4 |
Myocardial Infarction |
intron |
0.000354 |
GWASdb |
| chr19:11070244-11091864 |
chr19:11072610 |
rs11879293 |
SMARCA4 |
LDL lipoproteins |
intron |
7.54e-05 |
GWASdb |
| chr19:11070244-11091864 |
chr19:11084994 |
rs12610607 |
SMARCA4 |
Eosinophil counts |
intron |
5e-05 |
GWASdb |
| chr19:11070244-11091864 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
4e-26 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11084354 |
rs11668477 |
SMARCA4 - LDLR |
LDL cholesterol |
intergenic_variant |
2e-07 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
2e-26 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11091630 |
rs6511720 |
LDLR |
Carotid intima media thickness |
intron_variant |
1e-07 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11091630 |
rs6511720 |
LDLR |
Cardiovascular disease risk factors |
intron_variant |
5e-11 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipoprotein-associated phospholipase A2 activity and mass |
intron_variant |
3e-11 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
4e-117 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11091630 |
rs6511720 |
LDLR |
Cholesterol, total |
intron_variant |
7e-97 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11077477 |
rs55791371 |
SMARCA4 - LDLR |
Lipid metabolism phenotypes |
intergenic_variant |
8e-17 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11091630 |
rs6511720 |
LDLR |
Metabolite levels |
intron_variant |
4e-09 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipid metabolism phenotypes |
intron_variant |
5e-25 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipid metabolism phenotypes |
intron_variant |
3e-18 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipid metabolism phenotypes |
intron_variant |
1e-25 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipid metabolism phenotypes |
intron_variant |
2e-31 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11091630 |
rs6511720 |
LDLR |
Abdominal aortic aneurysm |
intron_variant |
2e-10 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
3e-115 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11089332 |
rs17249141 |
SMARCA4 - LDLR |
LDL cholesterol |
upstream_gene_variant |
2e-17 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
4e-262 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11091630 |
rs6511720 |
LDLR |
Cholesterol, total |
intron_variant |
5e-202 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
2e-51 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
7e-08 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11077571 |
rs56289821 |
SMARCA4 - LDLR |
Coronary artery disease |
intergenic_variant |
4e-15 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11078223 |
rs112374545 |
SMARCA4 - LDLR |
Cholesterol, total |
intergenic_variant |
2e-113 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11078223 |
rs112374545 |
SMARCA4 - LDLR |
LDL cholesterol |
intergenic_variant |
7e-142 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11077477 |
rs55791371 |
SMARCA4 - LDLR |
Myocardial infarction |
intergenic_variant |
3e-08 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11091630 |
rs6511720 |
LDLR |
Abdominal aortic aneurysm |
intron_variant |
8e-14 |
GWAS_Catalog |
| chr19:11070244-11091864 |
chr19:11079976 |
rs142130958 |
SMARCA4 - LDLR |
Metabolite levels (lipoprotein measures) |
intergenic_variant |
7e-47 |
GWAS_Catalog |
| chr19:11070269-11082396 |
chr19:11072610 |
rs11879293 |
SMARCA4 |
Myocardial Infarction |
intron |
0.000354 |
GWASdb |
| chr19:11070269-11082396 |
chr19:11072610 |
rs11879293 |
SMARCA4 |
LDL lipoproteins |
intron |
7.54e-05 |
GWASdb |
| chr19:11070269-11082396 |
chr19:11077477 |
rs55791371 |
SMARCA4 - LDLR |
Lipid metabolism phenotypes |
intergenic_variant |
8e-17 |
GWAS_Catalog |
| chr19:11070269-11082396 |
chr19:11077571 |
rs56289821 |
SMARCA4 - LDLR |
Coronary artery disease |
intergenic_variant |
4e-15 |
GWAS_Catalog |
| chr19:11070269-11082396 |
chr19:11078223 |
rs112374545 |
SMARCA4 - LDLR |
Cholesterol, total |
intergenic_variant |
2e-113 |
GWAS_Catalog |
| chr19:11070269-11082396 |
chr19:11078223 |
rs112374545 |
SMARCA4 - LDLR |
LDL cholesterol |
intergenic_variant |
7e-142 |
GWAS_Catalog |
| chr19:11070269-11082396 |
chr19:11077477 |
rs55791371 |
SMARCA4 - LDLR |
Myocardial infarction |
intergenic_variant |
3e-08 |
GWAS_Catalog |
| chr19:11070269-11082396 |
chr19:11079976 |
rs142130958 |
SMARCA4 - LDLR |
Metabolite levels (lipoprotein measures) |
intergenic_variant |
7e-47 |
GWAS_Catalog |